project id: TCGA-BRCA; case submitter id: TCGA-A2-A0D2; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.9; spectrophotometer method: UV Spec; age at index: 45; days to birth: -16623; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 16623; ajcc pathologic m: M0; ajcc pathologic n: N0 (i+); ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1027.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 614; initial weight: 330.0; sample id: 72439e36-3c17-4a90-b3e1-8f6ccfd3dcd4; sample submitter id: TCGA-A2-A0D2-01A; portion id: 43488211-b6e4-4f92-9ced-80f93f9b5343; portion submitter id: TCGA-A2-A0D2-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent tumor cells: 80.0;